Foghorn Therapeutics (FHTX) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to 0.11.
- Foghorn Therapeutics' Asset Utilization Ratio rose 4194.59% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year increase of 4194.59%. This contributed to the annual value of 0.08 for FY2024, which is 1978.66% down from last year.
- Latest data reveals that Foghorn Therapeutics reported Asset Utilization Ratio of 0.11 as of Q3 2025, which was up 4194.59% from 0.1 recorded in Q2 2025.
- Over the past 5 years, Foghorn Therapeutics' Asset Utilization Ratio peaked at 0.13 during Q1 2024, and registered a low of 0.0 during Q1 2021.
- In the last 5 years, Foghorn Therapeutics' Asset Utilization Ratio had a median value of 0.06 in 2023 and averaged 0.06.
- In the last 5 years, Foghorn Therapeutics' Asset Utilization Ratio surged by 112667.99% in 2022 and then tumbled by 3304.49% in 2024.
- Quarter analysis of 5 years shows Foghorn Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then skyrocketed by 1126.68% to 0.05 in 2022, then surged by 148.61% to 0.11 in 2023, then plummeted by 33.04% to 0.08 in 2024, then soared by 49.02% to 0.11 in 2025.
- Its last three reported values are 0.11 in Q3 2025, 0.1 for Q2 2025, and 0.09 during Q1 2025.